With three coronavirus vaccines in use in the U.S., there likely won’t be demand for a fourth vaccine option by the time the Novavax vaccine goes through the regulatory process.
from U.S. News - News https://ift.tt/3gn1mn1
from Yahoo News - Latest News & Headlines https://ift.tt/R2Yrilm
0 comments:
Post a Comment